8-methyl-4-phenyl-quinolin-2-ol | 70453-86-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 8-methyl-4-phenyl-quinolin-2-ol
• 英文别名: 8-Methyl-4-phenyl-chinolin-2-ol；8-methyl-4-phenyl-2-quinolinol；2-Hydroxy-8-methyl-4-phenyl-chinolin；4-Phenyl-8-methyl-2-hydroxy-chinolin；8-Methyl-4-phenyl-2-hydroxychinolin；8-methyl-4-phenyl-1H-quinolin-2-one
• CAS: 70453-86-0
• 化学式: C₁₆H₁₃NO
• mdl: MFCD02064713
• 分子量: 235.285
• InChiKey: SVACTKZQDNRSIM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  18
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.062
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  8-methyl-4-phenyl-quinolin-2-ol 在 三氯氧磷 作用下， 反应 7.0h， 生成 2-chloro-8-methyl-4-phenylquinoline
  参考文献：
  名称：

  5-苯基-[1,2,4]-三唑并[4,3-a]喹啉的合成及抗惊厥活性

  摘要：

  通过2-氯-4-苯基-1,2-二氢萘与甲酰肼的环化反应合成了一系列新型5-苯基-[1,2,4]-三唑并[4,3-a]喹啉衍生物。以 3-氧代-3-苯基丙酸乙酯和取代苯胺为原料合成了 2-氯-4-苯基-1,2-二氢萘。通过最大电休克 (MES) 试验评估它们的抗惊厥活性，通过旋转棒神经毒性试验 (Tox) 评估它们的神经毒性。最大电击试验表明，7-hexyloxy-5-phenyl-[1,2,4]-triazolo[4,3-a]quinoline 4f 是最有效的化合物，ED50 值为 6.5 mg/kg，并且保护指数（PI = ED50 / TD50）值为35.1，远高于参比药物苯妥英的PI。

  DOI：

  10.1002/ardp.200800116
• 作为产物：
  描述：

  3-oxo-3-phenyl-N-(o-tolyl)propanamide 在 PPA 、 Polyphosphoric acid (PPA) 作用下， 反应 0.5h， 生成 8-methyl-4-phenyl-quinolin-2-ol
  参考文献：
  名称：

  5-苯基-[1,2,4]-三唑并[4,3-a]喹啉的合成及抗惊厥活性

  摘要：

  通过2-氯-4-苯基-1,2-二氢萘与甲酰肼的环化反应合成了一系列新型5-苯基-[1,2,4]-三唑并[4,3-a]喹啉衍生物。以 3-氧代-3-苯基丙酸乙酯和取代苯胺为原料合成了 2-氯-4-苯基-1,2-二氢萘。通过最大电休克 (MES) 试验评估它们的抗惊厥活性，通过旋转棒神经毒性试验 (Tox) 评估它们的神经毒性。最大电击试验表明，7-hexyloxy-5-phenyl-[1,2,4]-triazolo[4,3-a]quinoline 4f 是最有效的化合物，ED50 值为 6.5 mg/kg，并且保护指数（PI = ED50 / TD50）值为35.1，远高于参比药物苯妥英的PI。

  DOI：

  10.1002/ardp.200800116

文献信息

• Pyridine and related aza heterocycle derivatives as cardiovascular agents
  申请人：AMERICAN CYANAMID COMPANY

  公开号：EP0446604A3

  公开（公告）日：1992-02-19

  Novel pharmaceutical compounds and compositions having nitrogen containing ring systems which may be represented by the following structural formula: wherein R₁ or R₃ is a moiety of the formula: wherein R₆ is selected from either hydrogen or acetyl; R₇ is selected from 2, 3 or 4-pyridyl or 1-imidazolyl and Q is -(CH₂)n, where n is an integer from 1 to 5 and R₁ and R₂, R₂ and R₃, R₃ and R₄ or R₄ and R₅ taken together may be -CH=CH-CH=CH-. The compounds and compositions are useful as inhibitors of thromboxane synthetase and in the treatment of hypertension and arrythmia in mammals.

  具有含氮环系统的新型药物化合物和组合物，可以用以下结构式表示： 其中R₁或R₃是以下式的基团： 其中R₆从氢或乙酰中选择；R₇从2、3或4-吡啶基或1-咪唑基中选择，Q为-(CH₂)n，其中n是从1到5的整数，且R₁和R₂、R₂和R₃、R₃和R₄或R₄和R₅一起可能是-CH=CH-CH=CH-。这些化合物和组合物可用作血栓素合酶的抑制剂，并用于治疗哺乳动物的高血压和心律失常。
• Synthesis and Anticonvulsant Activity of 5-Phenyl-[1,2,4]-triazolo[4,3-<i>a</i>]quinolines
  作者：Li-Ping Guan、Qing-Hao Jin、Shou-Feng Wang、Fu-Nan Li、Zhe-Shan Quan

  DOI：10.1002/ardp.200800116

  日期：2008.12

  A series of novel 5‐phenyl‐[1,2,4]‐triazolo[4,3‐a]quinoline derivatives was synthesized by the cyclization of 2‐chloro‐4‐phenyl‐1,2‐dihydronaphthalene with formohydrazide. The starting material 2‐chloro‐4‐phenyl‐1,2‐dihydronaphthalene was synthesized from ethyl‐3‐oxo‐3‐phenylpropanoate and substituted aniline. Their anticonvulsant activities were evaluated by the maximal electroshock (MES) test and

  通过2-氯-4-苯基-1,2-二氢萘与甲酰肼的环化反应合成了一系列新型5-苯基-[1,2,4]-三唑并[4,3-a]喹啉衍生物。以 3-氧代-3-苯基丙酸乙酯和取代苯胺为原料合成了 2-氯-4-苯基-1,2-二氢萘。通过最大电休克 (MES) 试验评估它们的抗惊厥活性，通过旋转棒神经毒性试验 (Tox) 评估它们的神经毒性。最大电击试验表明，7-hexyloxy-5-phenyl-[1,2,4]-triazolo[4,3-a]quinoline 4f 是最有效的化合物，ED50 值为 6.5 mg/kg，并且保护指数（PI = ED50 / TD50）值为35.1，远高于参比药物苯妥英的PI。
• Studies on proton pump inhibitors. II. Synthesis and antiulcer activity of 8-((2-benzimidazolyl)-sulfinylmethyl)-1,2,3,4-tetrahydroquinolines and related compounds.
  作者：Minoru UCHIDA、Masatoshi CHIHIRO、Seiji MORITA、Toshimi KANBE、Hiroshi YAMASHITA、Katsuya YAMASAKI、Youichi YABUUCHI、Kazuyuki NAKAGAWA

  DOI：10.1248/cpb.37.2109

  日期：——

  Many 8-[(2-benzimidazolyl)sulfinylmethyl]-1, 2, 3, 4-tetrahydroquinoline derivatives were synthesized and tested for their (H+ + K+)adenosine triphosphatase (ATPase)-inhibitory and antisecretory activities against histamine-induced gastric acid secretion in rats. These sulfinyl compounds were synthesized by the oxidation of the corresponding sulfides, which were obtained from the reaction of 8-chloromethyl-1, 2, 3, 4-tetrahydroquinolines and 2-mercaptobenzimidazoles in the presence of potassium carbonate. All compounds tested were potent inhibitors of (H+ + K+)ATPase. Most of the compounds showed antisecretory activity. Among them, 8-[(2-benzimidazolyl)sulfinylmethyl]-1-ethyl-1, 2, 3, 4-tetrahydroquinoline (IXa) was found to have the most potent activity. The structure-activity relationships are discussed.

  合成了许多8-[(2-苯并咪唑基)亚磺酰甲基]-1, 2, 3, 4-四氢喹啉衍生物，并测试了它们对(H+ + K+)腺苷三磷酸酶(ATPase)的抑制活性和对组胺诱导的大鼠胃酸分泌的抗分泌活性。这些亚磺酰化合物是通过氧化相应的硫化物合成的，这些硫化物是通过在碳酸钾存在下，8-氯甲基-1, 2, 3, 4-四氢喹啉与2-巯基苯并咪唑反应得到的。所有测试的化合物都是(H+ + K+) ATPase的强效抑制剂。大多数化合物显示出抗分泌活性。在这些化合物中，8-[(2-苯并咪唑基)亚磺酰甲基]-1-ethyl-1, 2, 3, 4-四氢喹啉(IXa)被发现具有最强的活性。讨论了结构－活性关系。
• EtOS₂K as a C1 Source: Solvent- and Temperature-Controlled Selective Synthesis of Quinoline-2-thione and Quinoline-2-one Derivatives
  作者：Yue Zhang、Yu-Jie Chen、Xiao-Dong Yue、Yu-Lian Zhang、Jin-Hong Jia、Ming Li、Xi-Cun Wang

  DOI：10.1021/acs.orglett.4c00561

  日期：2024.3.8

  Herein, we disclosed a highly chemoselective synthesis of quinoline-2-one and quinoline-2-thione derivatives using EtOS2K as the C1 source. Quinoline-2-one derivatives were synthesized selectively with NaCl as a catalyst in the solvent DMSO/H2O, while quinoline-2-thione derivatives were produced without the need for any catalyst in an environmentally friendly solvent EtOH/H2O. The reaction conditions

  在此，我们公开了使用 EtOS 2 K 作为 C1 源的喹啉-2-酮和喹啉-2-硫酮衍生物的高度化学选择性合成。在溶剂DMSO/H 2 O中以NaCl为催化剂选择性合成了喹啉-2-酮衍生物，而在环保溶剂EtOH/H 2 O中无需任何催化剂即可制备喹啉-2-硫酮衍生物。反应条件温和，具有良好的官能团耐受性。
• Potential antitumor agents. 56. Minimal DNA-intercalating ligands as antitumor drugs: phenylquinoline-8-carboxamides
  作者：Graham J. Atwell、Claudia D. Bos、Bruce C. Baguley、William A. Denny

  DOI：10.1021/jm00400a029

  日期：1988.5

  A series of isomeric phenylquinoline-8-carboxamides have been synthesized and evaluated as antitumor agents. This configuration is close to the minimum chromophore required for intercalative binding, since the binding mode of the compounds is dependent on the presence and position of the phenyl ring. If the ring is appended at the 4- or 5-position, it cannot lie within the DNA-intercalation site, and the compounds do not intercalate as shown by both unwinding and helix extension assays. In contrast, the 2-, 3-, and 6-phenyl isomers (where the phenyl ring lies coplanar with the quinoline and in the intercalation site) bind by intercalation. Only those isomers that intercalate show in vivo antitumor activity, with the 2-phenyl derivative in particular possessing broad-spectrum activity in both leukemia and solid-tumor assays.